{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:47:23Z","timestamp":1785826043019,"version":"3.56.0"},"reference-count":42,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<ns3:p>&lt;p&gt;&lt;strong&gt;Introduction:&lt;\/strong&gt; Cutaneous melanoma of the head and neck represents a distinct subtype of cutaneous melanoma with unique epidemiological, biological, diagnostic, and therapeutic characteristics. Although it accounts for approximately one-fifth of all cutaneous melanoma cases, it occurs more frequently in older individuals, more often arises in chronically sun-exposed skin, and is associated with a worse prognosis than melanomas at other anatomical sites. This review presents current knowledge on the epidemiology, aetiology, clinical presentation, diagnosis, and treatment of cutaneous melanoma of the head and neck, with particular emphasis on the specific features of this location.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Aim:&lt;\/strong&gt; The aim of this study was to present current diagnostic and treatment strategies for cutaneous melanoma of the head and neck, with particular emphasis on the unique features of this anatomical location.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Methods:&lt;\/strong&gt; This article is a narrative review informed by a structured literature search. The search was conducted in PubMed\/MEDLINE, Scopus, and Web of Science, covering publications from January 2014 to March 2026.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;\/strong&gt; Chronic ultraviolet radiation exposure remains the main aetiological factor, acting in conjunction with genetic predisposition and host phenotypic traits. The clinical presentation is diverse and includes both classic pigmented lesions and nodular, amelanotic, and lentigo maligna subtypes, with the latter being particularly common in chronically sun-damaged skin. Diagnosis requires an integrated approach involving clinical examination, dermoscopy, appropriately planned biopsy, and histopathological assessment, with selected cases also benefiting from non-invasive techniques, imaging studies, molecular diagnostics, and artificial intelligence-based tools. Sentinel lymph node biopsy remains a key component of regional staging. Surgical excision is the cornerstone of local treatment, although resection margins in this region often need to be individualised because of functional and aesthetic considerations. In recent years, systemic treatment, especially immunotherapy and targeted therapy, has gained major importance and has significantly improved outcomes in both the adjuvant and advanced disease settings.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions:&lt;\/strong&gt; Cutaneous melanoma of the head and neck requires multidisciplinary and individualised management, and improved prognosis depends on early diagnosis, accurate staging, and the appropriate use of modern therapeutic strategies.&lt;\/p&gt;<\/ns3:p>","DOI":"10.5604\/01.3001.0055.7695","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:12:33Z","timestamp":1781791953000},"page":"40-50","source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Melanoma of the Head and Neck: Contemporary Perspectives on Diagnosis and Management"],"prefix":"10.5604","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-5369","authenticated-orcid":false,"given":"Mateusz","family":"Szewczyk","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland, The Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Rusek","sequence":"additional","affiliation":[{"name":"The Greater Poland Cancer Center, Poznan, Poland, Department of Cancer Pathology and Prevention, The Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-6402","authenticated-orcid":false,"given":"Jakub","family":"Pazdrowski","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland, The Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3689","reference":[{"key":"638945r1","doi-asserted-by":"crossref","unstructured":"Long G.V., Swetter S.M., Menzies A.M., Gershenwald J.E., Scolyer R.A.: Cutaneous melanoma. The Lancet., 2023; 402(10400): 485\u2013502. doi: 10.1016\/S0140-6736(23)00821-8.","DOI":"10.1016\/S0140-6736(23)00821-8"},{"key":"638945r2","doi-asserted-by":"crossref","unstructured":"Ma C., Qin R., Cao Y. et al.: Nomogram Predicts Prognostic Factors for Headand Neck Cutaneous Melanoma: A Population-Based Analysis. World Neurosurg., 2024; 187: e839\u2013851. doi: 10.1016\/j.wneu.2024.04.176.","DOI":"10.1016\/j.wneu.2024.04.176"},{"key":"638945r3","doi-asserted-by":"crossref","unstructured":"Joshi U.M., Kashani-Sabet M., Kirkwood J.M.: Cutaneous Melanoma: A Review.JAMA., 2025; 334(23): 2113\u20132125. doi: 10.1001\/jama.2025.13074.","DOI":"10.1001\/jama.2025.13074"},{"key":"638945r4","doi-asserted-by":"crossref","unstructured":"Vikstr\u00f6m S., Mikiver R., Lapins J. et al.: Increasing melanoma incidence andsurvival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden. Br J Dermatol., 2023; 189(6): 702\u2013709. doi: 10.1093\/bjd\/ljad244.","DOI":"10.1093\/bjd\/ljad244"},{"key":"638945r5","doi-asserted-by":"crossref","unstructured":"Ding Y., Jiang R., Chen Y. et al.: Comparing the characteristics and predictingthe survival of patients with head and neck melanoma versus body melanoma: a population-based study. BMC Cancer., 2021; 21(1): 420. doi: 10.1186\/s12885-021-08105-y.","DOI":"10.1186\/s12885-021-08105-y"},{"key":"638945r6","doi-asserted-by":"crossref","unstructured":"Dereba\u015f\u0131nl\u0131o\u011flu H.: Distribution of skin cancers of the head and neck accordingto anatomical subunit. Eur Arch Otorhinolaryngol., 2022; 279(3): 1461\u20131466.doi: 10.1007\/s00405-021-06901-7.","DOI":"10.1007\/s00405-021-06901-7"},{"key":"638945r7","unstructured":"Ward W.H., Farma J.M.: Cutaneous Melanoma: Etiology and Therapy. CodonPublications, Brisbane 2017."},{"key":"638945r8","doi-asserted-by":"crossref","unstructured":"Druskovich C., Kelley J., Aubrey J., Palladino L., Wright G.P.: A Review of Melanoma Subtypes: Genetic and Treatment Considerations. J Surg Oncol., 2025;131(3): 356\u2013364. doi: 10.1002\/jso.27953.","DOI":"10.1002\/jso.27953"},{"key":"638945r9","doi-asserted-by":"crossref","unstructured":"Spoerl S., Spanier G., Reiter E. et al.: Head and neck melanoma: outcome andpredictors in a population-based cohort study. Head Face Med., 2021; 17(1): 45 doi: 10.1186\/s13005-021-00295-x.","DOI":"10.1186\/s13005-021-00295-x"},{"key":"638945r10","doi-asserted-by":"crossref","unstructured":"Lin D., Franc B.L., Kashani-Sabet M., Singer M.I.: Lymphatic drainage patternsof head and neck cutaneous melanoma observed on lymphoscintigraphy andsentinel lymph node biopsy. Head Neck., 2006; 28(3): 249\u2013255. doi: 10.1002\/hed.20328.","DOI":"10.1002\/hed.20328"},{"key":"638945r11","doi-asserted-by":"crossref","unstructured":"Olsen C.M., Pandeya N., Miranda-Filho A., Rosenberg P.S, Whiteman D.C.:Does Sex Matter? Temporal Analyses of Melanoma Trends among Men andWomen Suggest Etiologic Heterogeneity. J Invest Dermatol., 2025; 145(1):135\u2013143. doi: 10.1016\/j.jid.2024.05.011.","DOI":"10.1016\/j.jid.2024.05.011"},{"key":"638945r12","unstructured":"Swetter S.M., Johnson D., Albertini M.R. et al.: NCCN Guidelines Insights:Melanoma: Cutaneous, Version 2.2024. J Natl Compr Canc Netw., 2024;22(5): 290\u2013298."},{"key":"638945r13","doi-asserted-by":"crossref","unstructured":"Eggermont A.M.M., Blank C.U., Mandala M. et al.: Adjuvant Pembrolizumabversus Placebo in Resected Stage III Melanoma. N Engl J Med., 2018; 378(19):1789\u20131801. doi: 10.1056\/NEJMoa1802357.","DOI":"10.1056\/NEJMoa1802357"},{"key":"638945r14","doi-asserted-by":"crossref","unstructured":"Luke J.J., Ascierto P.A., Khattak M.A. et al.: Pembrolizumab versus placebo asadjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow--up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study. Eur J Cancer., 2025; 220: 115381. doi: 10.1016\/j.ejca.2025.115381.","DOI":"10.1016\/j.ejca.2025.115381"},{"key":"638945r15","doi-asserted-by":"crossref","unstructured":"Luke J.J., Rutkowski P., Queirolo P. et al.: LBA3 Pembrolizumab versus placeboafter complete resection of high-risk stage II melanoma: Efficacy and safety results from the KEYNOTE-716 double-blind phase III trial. Ann Oncol., 2021;32: S1314\u20131315. doi: 10.1016\/j.annonc.2021.08.2116.","DOI":"10.1016\/j.annonc.2021.08.2116"},{"key":"638945r16","doi-asserted-by":"crossref","unstructured":"Wolchok J.D., Chiarion-Sileni V., Rutkowski P. et al.: Final, 10-Year Outcomeswith Nivolumab plus Ipilimumab in Advanced Melanoma. N Engl J Med., 2025;392(1): 11\u201322. doi: 10.1056\/NEJMoa2407417.","DOI":"10.1056\/NEJMoa2407417"},{"key":"638945r17","doi-asserted-by":"crossref","unstructured":"Alsaade F.W., Aldhyani T.H.H., Al-Adhaileh M.H.: Developing a RecognitionSystem for Diagnosing Melanoma Skin Lesions Using Artificial Intelligence Algorithms. Comput Math Methods Med., 2021; 2021(1): 1\u201320. doi:10.1155\/2021\/9998379.","DOI":"10.1155\/2021\/9998379"},{"key":"638945r18","doi-asserted-by":"crossref","unstructured":"Guitera P., Pellacani G., Longo C. et al.: In Vivo Reflectance Confocal Microscopy Enhances Secondary Evaluation of Melanocytic Lesions. J Invest Dermatol., 2009; 129(1): 131\u2013138. doi: 10.1038\/jid.2008.193.","DOI":"10.1038\/jid.2008.193"},{"key":"638945r19","doi-asserted-by":"crossref","unstructured":"Marghoob A.A., Scope A.: The Complexity of Diagnosing Melanoma. J InvestDermatol., 2009; 129(1): 11\u201313. doi: 10.1038\/jid.2008.388.","DOI":"10.1038\/jid.2008.388"},{"key":"638945r20","doi-asserted-by":"crossref","unstructured":"Harrington E., Clyne B., Wesseling N. et al.: Diagnosing malignant melanomain ambulatory care: a systematic review of clinical prediction rules. BMJ Open.,2017; 7(3): e014096. doi: 10.1136\/bmjopen-2016-014096.","DOI":"10.1136\/bmjopen-2016-014096"},{"key":"638945r21","doi-asserted-by":"crossref","unstructured":"Chanda T., Hauser K., Hobelsberger S. et al.: Dermatologist-like explainableAI enhances trust and confidence in diagnosing melanoma. Nat Commun.,2024; 15(1): 524. doi: 10.1038\/s41467-023-43095-4.","DOI":"10.1038\/s41467-023-43095-4"},{"key":"638945r22","doi-asserted-by":"crossref","unstructured":"Menezes S.L., Kelly J.W., Wolfe R., Farrugia H., Mar V.J.: The increasing useof shave biopsy for diagnosing invasive melanoma in Australia. Med J Aust.,2019; 211(5): 213\u2013218. doi: 10.5694\/mja2.50289.","DOI":"10.5694\/mja2.50289"},{"key":"638945r23","doi-asserted-by":"crossref","unstructured":"Smith A.L., Watts C.G., Robinson S. et al.: GPs\u2019 involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneousmelanoma: a qualitative study. BJGP Open., 2020; 4:(2) bjgpopen20X101028.doi: 10.3399\/bjgpopen20X101028.","DOI":"10.3399\/bjgpopen20X101028"},{"key":"638945r24","doi-asserted-by":"crossref","unstructured":"Wong S.L., Faries M.B., Kennedy E.B. et al.: Sentinel Lymph Node Biopsy andManagement of Regional Lymph Nodes in Melanoma: American Society ofClinical Oncology and Society of Surgical Oncology Clinical Practice GuidelineUpdate. J Clin Oncol., 2018; 36(4): 399\u2013413. doi: 10.1200\/JCO.2017.75.7724.","DOI":"10.1200\/JCO.2017.75.7724"},{"key":"638945r25","doi-asserted-by":"crossref","unstructured":"Harrison C., Willis S., Harvey M.R. et al.: Sensitivity and negative predictivevalue of sentinel lymph node biopsy for cutaneous melanoma for diagnosingnodal metastasis: meta-analysis of diagnostic test accuracy. BJS Open., 2025;9(4): zraf089. doi: 10.1093\/bjsopen\/zraf089.","DOI":"10.1093\/bjsopen\/zraf089"},{"key":"638945r26","doi-asserted-by":"crossref","unstructured":"Mansini A., Aarohi S., Della Mura M. et al.: Sentinel Lymph Node Biopsy inMelanoma: Overview and Updates. Int J Mol Sci., 2025; 26(19): 9469. doi:10.3390\/ijms26199469.","DOI":"10.3390\/ijms26199469"},{"key":"638945r27","doi-asserted-by":"crossref","unstructured":"Bluemel C., Herrmann K., Giammarile F. et al.: EANM practice guidelines forlymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J NuclMed Mol Imaging., 2015; 42(11): 1750\u20131766. doi: 10.1007\/s00259-015-3135-1.","DOI":"10.1007\/s00259-015-3135-1"},{"key":"638945r28","doi-asserted-by":"crossref","unstructured":"Parrett B.M., Kashani\u2010Sabet M., Singer M.I. et al.: Long\u2010Term Prognosis andSignificance of the Sentinel Lymph Node in Head and Neck Melanoma. Otolaryngol Neck Surg., 2012; 147: 699\u2013706. doi: 10.1177\/0194599812444268.","DOI":"10.1177\/0194599812444268"},{"key":"638945r29","doi-asserted-by":"crossref","unstructured":"Patuzzo R., Maurichi A., Camerini T. et al.: Accuracy and prognostic value ofsentinel lymph node biopsy in head and neck melanomas. J Surg Res., 2014;187(2): 518\u2013524. doi: 10.1016\/j.jss.2013.10.037.","DOI":"10.1016\/j.jss.2013.10.037"},{"key":"638945r30","doi-asserted-by":"crossref","unstructured":"Obuchowska I., Dmuchowska D.A., Konopi\u0144ska J.: Advances in PositronEmission Tomography\/Computed Tomography for Diagnosing and Managing Primary Posterior Uveal Melanoma. Med Sci Monit., 2025; 31: e949252.doi: 10.12659\/MSM.949252.","DOI":"10.12659\/MSM.949252"},{"key":"638945r31","doi-asserted-by":"crossref","unstructured":"O\u2019Brien C., Coates A.S., Petersen-Schaefer K. et al.: Experience with 998cutaneous melanomas of the head and neck over 30 years. Am J Surg., 1991;162(4): 310\u2013314.","DOI":"10.1016\/0002-9610(91)90138-4"},{"key":"638945r32","doi-asserted-by":"crossref","unstructured":"C\u00e1novas Seva C., Mart\u00ednez Lebor\u00e1ns L., Batalla A. et al.: Lentigo Maligna:Contemporary Surgical Management and Outcome: A Review. Ann Ital Chir.,2026; 97(1): 36\u201362. doi: 10.62713\/aic.4228.","DOI":"10.62713\/aic.4228"},{"key":"638945r33","doi-asserted-by":"crossref","unstructured":"Khan F., Strohl A., Allen P.D., Doerr T.D.: Desmoplastic Melanoma of the Headand Neck: Incidence and Survival, 1992\u20102013. Otolaryngol Neck Surg., 2017;157(4): 648\u2013656. doi: 10.1177\/0194599817725696.","DOI":"10.1177\/0194599817725696"},{"key":"638945r34","doi-asserted-by":"crossref","unstructured":"Yee P., Shen C., Jeun C., Mayhew M., Witt R.G.: Sentinel Lymph Node Biopsyfor Desmoplastic Melanoma: A Systematic Review and Meta-analysis. AnnSurg Oncol., 2026. doi: 10.1245\/s10434-026-19498-0.","DOI":"10.1245\/s10434-026-19498-0"},{"key":"638945r35","doi-asserted-by":"crossref","unstructured":"Cochran A.J., Wen D.-R., Huang R.-R. et al.: Sentinel lymph node melanomametastases: Assessment of tumor burden for clinical prediction of outcome inthe first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Eur J SurgOncol., 2022; 48(6): 1280\u20131287. doi: 10.1016\/j.ejso.2022.01.021.","DOI":"10.1016\/j.ejso.2022.01.021"},{"key":"638945r36","doi-asserted-by":"crossref","unstructured":"Heino P.J., Pappinen J., Thompson J.F. et al.: Health-related Quality of Life andhospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II). Acta Oncol., 2025; 64:247\u2013256. doi: 10.2340\/1651-226X.2025.42314.","DOI":"10.2340\/1651-226X.2025.42314"},{"key":"638945r37","doi-asserted-by":"crossref","unstructured":"Faries M.B., Thompson J.F., Cochran A.J. et al.: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med., 2017;376(23): 2211\u20132222. doi: 10.1056\/NEJMoa1613210.","DOI":"10.1056\/NEJMoa1613210"},{"key":"638945r38","doi-asserted-by":"crossref","unstructured":"Weber J., Mandala M., Del Vecchio M. et al.: Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med., 2017; 377(19):1824\u20131835. doi: 10.1056\/NEJMoa1709030.","DOI":"10.1056\/NEJMoa1709030"},{"key":"638945r39","doi-asserted-by":"crossref","unstructured":"Miura J.T., Karakousis G.C.: Neoadjuvant Nivolumab and Ipilimumab for Resectable Stage III Melanoma: The New Standard of Care? Ann Surg Oncol.,2025; 32: 1394\u20131396. doi: 10.1245\/s10434-024-16807-3.","DOI":"10.1245\/s10434-024-16807-3"},{"key":"638945r40","doi-asserted-by":"crossref","unstructured":"Hadley C.E., Matsui J.K., Blakaj D.M. et al.: Delayed and Concurrent Stereotactic Radiosurgery in Immunotherapy-Na\u00efve Melanoma Brain Metastases. Cancers., 2024; 16: 3733. doi: 10.3390\/cancers16223733.","DOI":"10.3390\/cancers16223733"},{"key":"638945r41","doi-asserted-by":"crossref","unstructured":"Schadendorf D., Lord-Bessen J., Ejzykowicz F. et al.: Prognostic value of patient-reported outcomes in advanced or metastatic melanoma patients treatedwith immunotherapy: Findings from the CheckMate-067 study. Eur J Cancer.,2024; 213: 115099. doi: 10.1016\/j.ejca.2024.115099.","DOI":"10.1016\/j.ejca.2024.115099"},{"key":"638945r42","doi-asserted-by":"crossref","unstructured":"Tawbi H.A., Schadendorf D., Lipson E.J. et al.: Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. N Engl J Med., 2022; 386(1):24\u201334. doi: 10.1056\/NEJMoa2109970.","DOI":"10.1056\/NEJMoa2109970"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.7695","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.7695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:09:53Z","timestamp":1785823793000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0055.7695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0055.7695","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}